Zhao, Y., Huang, Y., Liu, H., Xiao, B., Zhang, L. (2025). Multi-omic analysis and overall survival update of phase II TRIDENT study: Durvalumab plus olaparib in extensive-stage small-cell lung cancer (ES-SCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8101